Abstract
BRAF and NRAS mutations have been described in melanomas among Caucasians and some Asian populations. However, few large-scale studies have investigated the status and clinical significance of BRAF and NRAS mutations in a Taiwanese population. Melanoma samples (n = 119) were analyzed for mutations in exons 11 and 15 of the BRAF gene, and in exons 1 and 2 of the NRAS gene. The samples were studied in genomic DNA, using polymerase chain reaction amplification and Sanger sequencing. Mutations of the BRAF and NRAS genes were then correlated with clinicopathological features and patients' prognosis. The incidence of somatic mutations within the BRAF and NRAS genes was 14.3% (17/119 patients) and 10.1% (12/119 patients), respectively. Among the 17 patients with BRAF mutations, 15 (88.2%) had V600E mutations. BRAF mutation was frequently detected in younger patients (p = 0.0035), in thin melanomas (p = 0.0181), and in melanomas with less ulceration (p = 0.0089). NRAS mutation was more often seen in patients with lymph node metastasis (p = 0.0332). Both BRAF and NRAS mutations were not significantly correlated with overall survival and disease-free survival. As BRAF and NRAS mutations are rare in Taiwan, BRAF- or NRAS-targeted therapie...Continue Reading
References
Feb 1, 1994·The Journal of Cell Biology·S M Frisch, H Francis
Jun 12, 2004·The Journal of Investigative Dermatology·Yoshinori SasakiAkira Horii
Apr 22, 2005·Biological Chemistry·Klaudia Giehl
Nov 18, 2005·The New England Journal of Medicine·John A CurtinBoris C Bastian
Dec 21, 2010·The British Journal of Dermatology·J-H LeeY-S Kim
Feb 18, 2011·Pigment Cell & Melanoma Research·Jürgen BauerBoris C Bastian
Feb 18, 2011·The Journal of Investigative Dermatology·Rui-Qun QiXing-Hua Gao
Jul 27, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lu SiJun Guo
Dec 20, 2011·The British Journal of Dermatology·F DurbecF Grange
Mar 23, 2012·The Journal of Investigative Dermatology·Qi-Ming ZhouXiao-Shi Zhang
Apr 27, 2012·Journal of Dermatological Science·Atsuko AshidaRyuhei Okuyama
Sep 28, 2012·The Journal of Investigative Dermatology·Sun A JinSook Jung Yun
Oct 17, 2012·Oncogene·I V FedorenkoK S M Smalley
Jun 7, 2013·International Journal of Clinical Oncology·Hisashi UharaRyuhei Okuyama
Sep 3, 2013·Journal of Dermatological Science·Abdlsattar ZebaryJohan Hansson
Jun 3, 2014·Annals of Dermatology·Jin-Woo HongKi-Hoon Song
Jul 23, 2014·Melanoma Research·Naoya YamazakiKoji Tsuta
Citations
Feb 16, 2017·Asia-Pacific Journal of Clinical Oncology·John Wen-Cheng ChangNaoya Yamazaki
May 5, 2016·Advances in Anatomic Pathology·Brendon MitchellMeera Mahalingam
Apr 15, 2020·Acta Oncologica·L NyJ Geisler
Aug 14, 2019·The British Journal of Dermatology·Y-S SheenC-Y Chu
Sep 9, 2017·Oncotarget·Marina EmelyanovaTatiana Nasedkina
Jul 23, 2020·JAMA Dermatology·Bin Wu, Lizheng Shi
Mar 1, 2016·Melanoma Management·Russell W Jenkins, Ryan J Sullivan
Jul 6, 2019·Melanoma Research·Luz Dary Gutiérrez-CastañedaJosé D Tovar-Parra
Jan 1, 2020·BMC Proceedings·Hanggoro Tri Rinonce Irianiwati
Mar 20, 2020·BMC Research Notes·Hanggoro Tri Rinonce Irianiwati
Jan 6, 2021·ESMO Open·S ByeonS T Kim
Jan 16, 2021·The British Journal of Dermatology·Y-S Sheen, C-Y Chu
Jun 3, 2021·Biology·Kuan-Jou WuChien-Chin Chen
Jun 11, 2021·Cancer Reports·Hanggoro Tri Rinonce Irianiwati
Jul 2, 2021·Annals of the Academy of Medicine, Singapore·Pei Ming YeoMelissa Wee Ping Tan